Neusoft Corporation: The special fund plans to acquire an 8.34% equity stake in Neusoft Medical for RMB 1.083 billion.

Neusoft Corporation announced that a special fund in which the company participates as a limited partner plans to acquire, in cash, an 8.3412% equity stake in Neusoft Medical held by Neusoft Holdings, for a transaction consideration of RMB 1.083 billion. This transaction constitutes a related-party transaction, does not constitute a major asset restructuring, and still needs to be submitted to the company's shareholders' meeting for review. In 2025, Neusoft Medical launched new products including China's first photon-counting CT and the world's first 1024-slice wide-body ultra-high-definition CT, and these entered volume production and shipment in succession in 2026, accelerating the commercialization of high-end products.